Results 11 to 20 of about 21,828,911 (99)

Patient journey in erosive oesophagitis: real-world perspectives from US physicians and patients. [PDF]

BMJ Open Gastroenterol, 2022
Vaezi MF, Brunton S, Mark Fendrick A, Howden CW, Atkinson C, Pelletier C, Jacob R, Spechler SJ.   +7 more
europepmc   +1 more source

Proton Pump Inhibitors and Bone Health: An Update Narrative Review. [PDF]

Int J Mol Sci, 2022
Lespessailles E, Toumi H.
europepmc   +1 more source

Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis. [PDF]

BMC Gastroenterol, 2023
Haruma K, Kinoshita Y, Yao T, Kushima R, Akiyama J, Aoyama N, Kanoo T, Miyata K, Kusumoto N, Uemura N.   +9 more
europepmc   +1 more source

Utility of the ¹³ C-pantoprazole breath test as a CYP2C19 phenotyping probe for children. [PDF]

Clin Transl Sci, 2022
Feldman K, Kearns GL, Pearce RE, Abdel-Rahman SM, Steven Leeder J, Friesen A, Staggs VS, Gaedigk A, Weigel J, Shakhnovich V.   +9 more
europepmc   +1 more source

Prazoles Targeting Tsg101 Inhibit Release of Epstein-Barr Virus following Reactivation from Latency. [PDF]

J Virol, 2021
Mannemuddhu SS, Xu H, Bleck CKE, Tjandra N, Carter C, Bhaduri-McIntosh S.   +5 more
europepmc   +1 more source

Identification of the New In Vivo Metabolites of Ilaprazole in Rat Plasma after Oral Administration by LC-MS: In Silico Prediction of the H⁺/K⁺-ATPase Inhibitor. [PDF]

Molecules, 2021
Zhang G, Guo K, Wang P, Shan Y, Ma C.
europepmc   +1 more source

Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>. [PDF]

ACS Infect Dis, 2023
Jeffreys LN, Ardrey A, Hafiz TA, Dyer LA, Warman AJ, Mosallam N, Nixon GL, Fisher NE, Hong WD, Leung SC, Aljayyoussi G, Bibby J, Almeida DV, Converse PJ, Fotouhi N, Berry NG, Nuermberger EL, Upton AM, O'Neill PM, Ward SA, Biagini GA.   +20 more
europepmc   +1 more source

Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients. [PDF]

Clin Transl Sci, 2021
Zhao YC, Lin XB, Zhang BK, Xiao YW, Xu P, Wang F, Xiang DX, Xie XB, Peng FH, Yan M.   +9 more
europepmc   +1 more source

Simultaneous Quantitative Analysis of Six Proton-Pump Inhibitors with a Single Marker and Evaluation of Stability of Investigated Drugs in Polypropylene Syringes for Continuous Infusion Use. [PDF]

Drug Des Devel Ther, 2020
Chen F, He X, Fang B, Wang S.
europepmc   +1 more source

The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori. [PDF]

Medicine (Baltimore), 2020
Lee SW, Moon SJ, Kim SH, Jung SH, Song KH, Kim SM, Sung JK, Lee DS.   +7 more
europepmc   +1 more source